课题基金 / 基金详情

RNASE P RIBOZYMES FOR ANTIVIRAL APPLICATIONS

RNASE P RIBOZYMES FOR ANTIVIRAL APPLICATIONS
用于抗病毒应用的核糖核酸酶核酶
批准号:
6017097
负责人:
Fenyong Liu
金额:
$17.49万
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-06-01 至 2001-05-31

项目摘要

项目成果

Fenyong Liu的其他基金

相似基金

相关文献

中文摘要
翻译
描述:本提案的目的是研究催化
英文摘要
DESCRIPTION: The objective of this proposal is to study the catalytic mechanisms of ribonuclease P ribozymes and their applications for inhibition of viral gene expression. The applicant has constructed a ribozyme engineered from the catalytic RNA subunit of RNase P from E. coli. This new ribozyme cleaves RNA substrates, including viral mRNAs, that base pair to its guide sequence. It order to increase the cleavage efficiency, the applicant will conduct experiments to elucidate the mechanism of catalysis and substrate recognition. He will also test whether viral replication can be abolished by targeting an essential viral gene, ICP4. Ribozyme recognition of target mRNA will be studied by both in vitro kinetic and physical mapping analyses. Efficient ribozymes will be generated by either site-directed mutagenesis or in vitro selection. The requirements for efficient ribozyme activity in tissue culture will be defined and the sequence specificity determined. Finally, whether the engineered ribozyme can inhibit HSV-1 viral replication by abolishing ICP4 expression will be investigated. The long term goal is to develop a system to study RNA catalysis and its use as a gene-targeting tool in basic research and clinical applications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Persistent infection of human cytomegalovirus in oral mucosa
Persistent infection of human cytomegalovirus in oral mucosa
Persistent infection of human cytomegalovirus in oral mucosa
Human cytomegalovirus chromatin modifications in oral infection
海外基金